Navigation Links
FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
Date:5/28/2008

TIRAT CARMEL, Israel, May 28 /PRNewswire/ --

- Study Will Compare Birth Rates of Women who Underwent Non-Invasive MRgFUS to Those who had Invasive Fibroid Surgery

InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) cleared the company to conduct a clinical trial to evaluate the efficacy and safety of the ExAblate(R) 2000 system utilizing MR-guided Focused Ultrasound Surgery (MRgFUS) for the enhancement of fertility in women with non-hysteroscopically resectable uterine fibroids who are diagnosed with unexplained infertility.

Twenty U.S. and international sites will enroll a total of 650 women with uterine fibroids who are diagnosed with unexplained infertility. Half the women will undergo treatment with the ExAblate system, while the other half will have their fibroids surgically removed.

The study will measure the safety of each procedure, including pregnancy and delivery-related complications. The main efficacy goal of the trial will be to measure which procedure leads to a higher percentage of healthy live births resulting from pregnancies three to 15 months after treatment. Researchers will also examine the cost of treatment and any additional clinically required medical encounters and/or medications outside the study visits.

"While the link between uterine fibroids and infertility isn't fully understood, many women with uterine fibroids and infertility give birth to healthy babies after having their fibroids surgically removed," said Elizabeth A. Stewart, MD, a reproductive endocrinologist and Professor of Obstetrics and Gynecology at Mayo Clinic in Rochester, Minnesota. "The non-invasive ExAblate system precisely targets fibroid tissue without causing damage to the surrounding healthy areas, suggesting that it may be a safe approach for women with fibroids who want to preserve their fertility."

Accumulating clinical evidence shows that women have been able to conceive and successfully
'/>"/>

SOURCE InSightec Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
2. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
3. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
4. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
5. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
6. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
7. Abbott Presents Long-Term Data From Extension Study Showing Adult Crohns Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
8. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
9. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
10. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
11. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...on for Targeted Therapies That Ensure...BEACH, Calif., and AMSTERDAM, Netherlands, Sept. 4...lar cancer diagnostics,today announced the launch...ows physicians to quantitatively determine the gen... progesterone receptor (PR) and Human Epidermal,gr...
(Date:9/3/2008)...arch and Education Foundation,s Within Our Reach ... Treating and Understanding RA...time during its,unprecedented initiative to find a...ge of Rheumatology Research and Education Foundati...arch funded by the Within Our,Reach: Finding a Cur...
(Date:9/3/2008)...edarone) decreased the risk of,stroke by 34% in pa...lready adequately treated by antithro...swire-FirstCall/ -- The results of a,post-hoc anal...ted today at,the clinical trial update session of ...in Munich, Germany. Previous results from the land...
(Date:9/3/2008)...rstCall/ -- A sub-analysis of,the TRITON-TIMI 38 c...,compared with clopidogrel significantly reduced t...cent vs. 9.7 percent, p<0.0001), regardless,of whe...ery-opening,procedure known as percutaneous corona...eously during the longer-term maintenance phase. T...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6Protect Your Adolescents Against More Than Just A Cold This Winter 12551 1Protect Your Adolescents Against More Than Just A Cold This Winter 12551 2Prime Your Immune System During the Peak of Cold Season and Beyond 12548 1Prime Your Immune System During the Peak of Cold Season and Beyond 12548 2Americas 50 best hospitals 2008 released by HealthGrades 12545 1Americas 50 best hospitals 2008 released by HealthGrades 12545 2Americas 50 best hospitals 2008 released by HealthGrades 12545 3Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In Hospital Infections 12542 1Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In Hospital Infections 12542 2Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In Hospital Infections 12542 3Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In Hospital Infections 12542 4
...re-FirstCall/ -- Keryx,Biopharmaceuticals, Inc. to...) (sulodexide oral gelcap) have been selected for,...ions scheduled to,take place at the upcoming Ameri...fic Sessions and exposition at the McCormick Place... these abstracts, which highlight the mechanism of...
...Jun 21, 2007 - Advanced Cell,Technology, Inc. (OTC...nic stem cell (hESC) line without destroying an em...development was announced by,Robert Lanza, M.D., V...nced Cell Technology (ACT) on Tuesday at the fifth...tem Cell Research (ISSCR),in Cairns, Australia., I...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 4Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 2Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 3
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ith testicular cancer has increased significantly ...ch has now shown that fatherhood is a reachable po... Testicular cancer is the most common form of canc...tly more common on the right side than on the left...
...CG of the University of Iowa and colleagues at the...hat Gatorade and Pedialyte are equally effective a...m and vomiting related to acute viral gastroenteri...ed their findings at the 70th Annual Scientific Me...
...he American Association for Cancer Research (AACR)...rian food protects the host body from cancer occur...ting broccoli sprouts which is found to be effecti...to stomach and oral cancers. An other study has sh...
Avian flu-free India Considers Importing Vaccine
Other Medicine News:Health News:Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: